Get Details: First Stock to Potentially Accumulate Rs 7 Crore Long-term Wealth
Dr. Reddy's is a leading pharmaceutical company in the country with presence across the pharmaceutical value chain - basic research, finished dosages, generics, bulk actives, and biotechnology. The company's business is mainly organized into Global generics segment, PSAI (pharmaceutical services and active ingredients) and Proprietary products. The company has key presence is in India, North America, Russia and CIS countries, Europe and other emerging markets. The company has wide portfolio in several markets and has made several niche and Para IV launches.
American Depository Receipts | Feb 24, 2021 | ||
---|---|---|---|
Price (US$)61.00 | Open (US$)60.58 | High (US$)61.12 | Low (US$)60.22 |
% Change-0.20 | Volume266,000 | Value (US$)16,226,000 | 52-Week H/L73.50 / 33.33 |
Sorry! There are no related views on news for this company/sector.
In this video, I'll cover your queries on intraday trading and also share my view on how to decide stop losses and target prices.
This is first of the three part master series. In these editorials, I'll show you how to earn 10X returns from a penny stock portfolio over 10 years.
A look at what India's top equity mutual funds bought and sold in January 2021.
Do you enjoy reading Tesla and Bitcoin stories? Here's a not so famous small-cap stock to profit from the rise of EVs.
More